IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.
Stock data | 2024 | Change |
---|---|---|
Price | $2.11 | N/A |
Market Cap | $28.26M | N/A |
Shares Outstanding | 13.39M | N/A |
Employees | 0 | N/A |